Back

The impact of climate and demographic changes on future chikungunya burden and the potential role of vaccines: a mathematical modelling study

Cortes-Azuero, O.; Finch, E.; Ribeiro dos Santos, G.; Sutcliffe, E.; Scarponi, D.; Ryan, S. J.; Salje, H.

2026-02-17 infectious diseases
10.64898/2026.02.16.26346397 medRxiv
Show abstract

BackgroundChikungunya virus (CHIKV) is an Aedes transmitted arbovirus. Demographic changes coupled with the expanding footprint of the mosquito from climate change have the potential to shift the global burden from the virus. MethodsHere we use projections of human demography and Aedes mosquitoes distribution to estimate baseline and future burden from CHIKV under different climate change scenarios in 178 countries. We then estimate the potential of vaccines to mitigate the growing burden. FindingsWe found that under RCP2.6 (an optimistic climate change scenario), the global population at risk from CHIKV will increase by 30.2% to 5.4 billion individuals. We estimated a 35% increase in annual infections, 49% increase in cases and a 128% increase in deaths. A similar impact was found under the more pessimistic RCP8.5 climate change scenario. In Europe and the Americas, the growing presence of Aedes will drive the growing case burden, with increases in human population size being key elsewhere. Ageing populations will result in major increases in the number of CHIKV-related deaths in all continents outside Africa. Vaccinating 50% of individuals aged 12y+ with a vaccine providing 70% protection against disease and 40% protection against infection would avert 29% of cases and 31% of deaths. InterpretationThese findings highlight how climate change will expand the footprint of CHIKV circulation, while demographic changes will lead to substantially increased case burden in affected countries. Vaccines will be critical to minimising this changing global burden. FundingCEPI

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

1
The Lancet Infectious Diseases
71 papers in training set
Top 0.1%
21.8%
2
The Lancet Global Health
24 papers in training set
Top 0.2%
6.1%
3
Clinical Infectious Diseases
231 papers in training set
Top 1%
4.7%
4
The Lancet
16 papers in training set
Top 0.1%
4.2%
5
The American Journal of Tropical Medicine and Hygiene
60 papers in training set
Top 1.0%
4.0%
6
Nature Communications
4913 papers in training set
Top 38%
3.8%
7
International Journal of Infectious Diseases
126 papers in training set
Top 0.6%
3.5%
8
PLOS Medicine
98 papers in training set
Top 1%
3.5%
50% of probability mass above
9
The Journal of Infectious Diseases
182 papers in training set
Top 1%
3.5%
10
Emerging Infectious Diseases
103 papers in training set
Top 0.7%
3.0%
11
BMC Infectious Diseases
118 papers in training set
Top 1%
3.0%
12
PLOS Neglected Tropical Diseases
378 papers in training set
Top 2%
2.6%
13
BMJ Open
554 papers in training set
Top 7%
2.5%
14
Nature Medicine
117 papers in training set
Top 1%
2.4%
15
BMC Medicine
163 papers in training set
Top 3%
2.0%
16
Annals of Internal Medicine
27 papers in training set
Top 0.3%
2.0%
17
Journal of Travel Medicine
18 papers in training set
Top 0.1%
2.0%
18
Vaccine
189 papers in training set
Top 1%
1.7%
19
BMJ Global Health
98 papers in training set
Top 2%
1.6%
20
PLOS ONE
4510 papers in training set
Top 56%
1.6%
21
Science
429 papers in training set
Top 16%
1.3%
22
JAMA Network Open
127 papers in training set
Top 3%
1.2%
23
New England Journal of Medicine
50 papers in training set
Top 0.6%
1.1%
24
BMC Public Health
147 papers in training set
Top 5%
0.9%
25
Open Forum Infectious Diseases
134 papers in training set
Top 2%
0.9%
26
The Lancet Microbe
43 papers in training set
Top 1%
0.8%
27
PLOS Global Public Health
293 papers in training set
Top 6%
0.7%
28
Eurosurveillance
80 papers in training set
Top 2%
0.7%
29
Clinical Microbiology and Infection
60 papers in training set
Top 1%
0.7%
30
eClinicalMedicine
55 papers in training set
Top 2%
0.7%